Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity

X Xiuning Le (Department of Thoracic/Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA) J Jacqulyne P. Robichaux M Monique Nilsson R R. S. K. Vijayan A Ashwin Ravichandran J Jia Wu Y Yasir Y. Elamin L Lingzhi Hong J Jun Pei J Jun He S Sonia Patel H Hibiki Udagawa S Sriramvignesh Mani C Chang Woon Jang J Jeffrey M. Clarke N Nishan Tchekmedyian J Jonathan W. Goldman M Mark Socinski G Gajanan Bhat S Sharon Leu V Veronica Bunn Z Zhenqiang Su S Sylvie Vincent J John W. Lawson (Intelligent Systems Division) J Jason B. Cross J John V. Heymach